Tag: Owens & Minor
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’
February 20, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported revenue of $709 million for the fourth quarter ended Dec. 31, 2025.
For the full year 2025, it reported $2.8 billion, representing 3% growth vs. prior year. Results, unless otherwise noted, reflect the company’s Patient Direct business, said executives.
The company ended the fourth quarter with the completion of the sale of its Products & Healthcare Services (P&HS) business on Dec. 31, 2025, to Platinum Equity for $375 million, and began...
It’s official: Accendra Health goes live on NYSE, unveils new website
January 5, 2026HME News Staff
RICHMOND, Va. – Accendra Health began trading on the New York Stock Exchange on Jan. 2 under the ticker symbol ACH. The company also launched a new website: www.accendrahealth.com. This follows the completion of the sale of its former Products & Healthcare Services business and the transition away from its Owens & Minor brand. Accendra Health has said the name change affects only the name of the parent corporation and is intended to...
In brief: Accendra executive changes, BFLOW’s anniversary, Re-Time's smart ring
January 2, 2026HME News Staff
RICHMOND, Va. – Owens & Minor, now operating as Accendra Health, has announced the departure of two executives in connection with the sale of its Products & Healthcare Services, which closed Dec. 31. Andrew G. Long, executive vice president, CEO of Products & Healthcare Services, and Michael Lowry, senior vice president, corporate controller and chief accounting officer have left the company. Jonathan Leon, executive vice president & CFO since September...
Two execs exit Accendra Health as Products & Healthcare Services sale closes
January 2, 2026HME News Staff
RICHMOND, Va. – Owens & Minor, now operating as Accendra Health, has announced the departure of two executives in connection with the sale of its Products & Healthcare Services business, which closed Dec. 31. Andrew G. Long, executive vice president, CEO of Products & Healthcare Services, and Michael Lowry, senior vice president, corporate controller and chief accounting officer have left the company. Jonathan Leon, executive vice...
In brief: Accendra’s debut, Medline’s share price, OSA’s link to heart health
December 19, 2025HME News Staff
RICHMOND, Va. – Owens & Minor, Inc. will change its name to Accendra Health, Inc. with an anticipated effective date of Dec. 31.
The name change affects only the name of the parent corporation and is intended to better reflect the company’s strategic direction and future organizational focus as a leader in the home-based care market. The company will continue to use and operate under the Apria and Byram Healthcare brands.
Earlier this year,...
Owens & Minor to kick off new year with new name: Accendra Health
December 18, 2025HME News Staff
RICHMOND, Va. – Owens & Minor, Inc. will change its name to Accendra Health, Inc. with an anticipated effective date of Dec. 31.
The name change affects only the name of the parent corporation and is intended to better reflect the company’s strategic direction and future organizational focus as a leader in the home-based care market. The company will continue to use and operate under the Apria and Byram Healthcare brands.
Earlier this year,...
In brief: Resmed cleared for smart settings, Perry Bernocchi promoted, Lingo access expanded
December 9, 2025HME News Staff
SAN DIEGO – Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled device that recommends personalized comfort settings to help people with obstructive sleep apnea (OSA) start and stay on CPAP therapy.
Personalized Therapy Comfort Settings (PTCS), which will be marketed as Smart Comfort, will launch in early 2026 in a limited beta version in the United States for new users of myAir paired...
Owens & Minor names Bernocchi EVP & COO
December 9, 2025HME News Staff
RICHMOND, Va. - Owens & Minor has appointed Perry Bernocchi executive vice president and COO, according to a Form 8-K filed with the U.S. Securities and Exchange Commission. Since March 2023, he has served as executive vice president and CEO of the company’s Patient Direct segment. Earlier this year, Owens & Minor signed a definitive agreement to sell its Products & Healthcare Services (P&HS) segment, in a move that the company said supports...
Owens & Minor rebrands to sharpen focus on home-based care
October 31, 2025Theresa Flaherty, Managing Editor
RICHMOND, Va. – Owens & Minor is rebranding to reflect its strategic focus on the Patient Direct business, according to Edward Pesicka, the company’s president, CEO and director. The move follows the company’s October announcement of a definitive agreement to sell its Products & Healthcare Services (P&HS) segment to Platinum Equity for $375 million in cash.
“As I think about the future, following the divestiture of Products & Healthcare...
Owens & Minor reports Q3 results as it moves forward with Patient Direct
October 30, 2025HME News Staff
RICHMOND, Va. – Owens & Minor reported revenue of $697.3 million for the third quarter of 2025, compared to $686.8 million for the prior year quarter.
Adjusted EDITDA was $92.2 million, compared to $107.7 million the prior year.
The results represent the company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations.
Owens & Minor announced in October it had signed...